Eyenovia, Inc. (NASDAQ:EYEN)
Industry: PharmaceuticalsMajor

Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat, which is in Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.

Current Quote*
Last: $6.200
Change: -0.110
Book: $4.432
Volume: 5,935

As Of: 04/24 13:18 ET
*Quotes delayed by 20min.

Graphs for EYEN


3 Month Graph


6 Month Graph


1 Year Graph